Drug Information Association NewsSubscribe to Articles
The Drug Information Association (DIA) announces the addition of William J. Brassington, CPA to its management team as chief financial officer.
The Drug Information Association (DIA) announces the addition of Marlynn Orlando to its management team as director of volunteer and member services.
The Drug Information Association (DIA) today announced an alliance with The C-Path Institute, a non-profit organization whose purpose is to create programs in education and research to enable the safe acceleration of new medical product development.
Japanese regulators Ministry of Health, Labor and Welfare (MHLW), Pharmaceuticals and Medical Devices Agency (PMDA) and the Japan Pharmaceutical Manufacturers Association (JPMA) have endorsed the Drug Information Association's (DIA) upcoming Congress...
Planning moves ahead for the 42nd DIA Annual Meeting, which will take place at the Pennsylvania Convention Center in Philadelphia, June 18 to 22, 2006. Charles C. Depew, PharmD (GlaxoSmithKline) will serve as the program chairperson.
Statistical Methodology in Clinical & Non Clinical R&D
The Drug Information Association (DIA) will host Clinical Drug Development from Strategy to Implementation November 29 to December 1 at the Sheraton Inner Harbor Hotel in Baltimore.
The Drug Information Association (DIA) will host Ethical, Practical and Regulatory Issues in Pediatric Clinical Trials October 25- 26 at the Washington D.C. Marriott Hotel.
DIA will host its 18th Annual EuroMeeting March 6-8, 2006 at Le Palais des Congrès in Paris. The program will address the latest developments in important European initiatives, including pediatrics, advanced therapies, the technology platform, pharm...
The 42nd Annual Meeting is an event attended by pharmaceutical, biotechnology, and regulatory professionals from around the world.